[
    [
        {
            "time": "",
            "original_text": "上市药企较行业整体情况乐观 新和成大赚25亿",
            "features": {
                "keywords": [
                    "上市药企",
                    "行业整体情况",
                    "乐观",
                    "新和成",
                    "25亿"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上市药企较行业整体情况乐观 新和成大赚25亿",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[看好评级] 医药行业2018年中期投资策略：医药一枝独秀上半年全面牛 暂时调整后下半年看结构牛行情",
            "features": {
                "keywords": [
                    "医药行业",
                    "2018年",
                    "中期投资策略",
                    "一枝独秀",
                    "全面牛",
                    "暂时调整",
                    "结构牛行情"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[看好评级] 医药行业2018年中期投资策略：医药一枝独秀上半年全面牛 暂时调整后下半年看结构牛行情",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]